Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology

FDA approves blood test to help rule out Alzheimer’s disease in people with symptoms

(CNN) — The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the disease can be ruled out. Roche Diagnostics said Monday that its Elecsys pTau181 test, developed in collaboration with Indianapolis-based Lilly, could be used by primary care physicians to help identify patients who are unlikely to have Alzhei…

Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (FDA) has cleared its Elecsys pTau181...

FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related related Amyloid Pathology | NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Roche's Elecsys pTau181 test receives FDA clearance, revolutionizing Alzheimer’s diagnosis in primary care with a minimally invasive blood test.

Roche, Lilly's blood test for Alzheimer's diagnosis gets US approval - Express Pharma

Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly’s blood test as an aid in the initial assessment for Alzheimer’s disease. This comes at the heel of FDA’s nod for Fujirebio Diagnostics’ blood test Lumipulse in May, the first such device to get approval to diagnose the brain-wasting condition. Roche’s test Elecsys measures pTau181, a key protein associated with Alzheimer’s disease. It is int…

FDA clears Roche's blood-based test for Alzheimer's assessment

The US FDA has granted clearance for Roche's Elecsys pTau181 test for the preliminary evaluation of Alzheimer's disease.The post FDA clears Roche’s blood-based test for Alzheimer’s assessment appeared first on Medical Device Network.